semaglutide legal FBI warns about counterfeit weight loss drugs The Legal Landscape Is Semaglutide

WEGOVY is not recommended in patients with severe gastroparesis. The label does not mention that Wegovy could cause gastroparesis, a claim in many Wegovy lawsuits

Semaglutide is a Glucagon-like Peptide-1 receptor agonists (GLP-1 agonists), and has become a commonly prescribed drug for weight-loss

Its dual GIP and GLP-1 activity may contribute to its strong results

STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity Full Text View ClinicalTrials.gov

In fact, it helps build your gut biome, supports your intestinal tract's rebuilding efforts, and it will even settle your stomach

Research also suggests that the effects of cardiometabolic health can be affected following discontinuation of semaglutide use, which can increase risk factors for obesity related diseases such as diabetes and hypertension